Newsroom
Sorted by: Latest
-
Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA™ Robotic Surgical System, the world’s first table-integrated soft tissue robotic system. The system received marketing authorization for multiple procedures in general surgery, including Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, small bowel resection, appendectomy, lysis of adhesio...
-
BostonGene and Kyoto University Establish Strategic Partnership to Advance Biomarker Discovery for Combination Immunotherapy
TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, the developer of the leading AI model for tumor and immune biology, today announced a strategic research partnership with Kyoto University, a research institution known for its groundbreaking advancements in medicine and science. The partnership supports a multicenter, Phase II clinical trial led by Dr. Manabu Muto of Kyoto University, evaluating the safety and efficacy of a combined therapeutic approach using immune checkpoint inhibitors (IC...
-
Philadelphia Brings Its Signature Cream Cheese to Millions More Consumers with New Lactose Free Innovation
PITTSBURGH & CHICAGO--(BUSINESS WIRE)--For up to 50 million Americans who are lactose intolerant,1 cream cheese has often meant compromise – or going without altogether. Now, Philadelphia, the inventor of cream cheese, is changing that with the launch of Philadelphia Lactose Free, the first major brand to offer a lactose-free cream cheese in the U.S. Made with real dairy and delivering the same rich, creamy taste consumers expect from Philadelphia, the new innovation reflects Kraft Heinz’s stra...
-
Healthcare Services Group Reports Second Quarter Results
BENSALEM, Pa.--(BUSINESS WIRE)--Healthcare Services Group Reports Second Quarter Results, Delivers Strong Results, and Reaffirms 2026 Growth Outlook...
-
Introducing Halo: Archer’s Commercial Variant of Dual-Use Autonomous VTOL Aircraft Platform Developed With Anduril
FARNBOROUGH, England--(BUSINESS WIRE)--Archer Aviation (NYSE: ACHR) today announced Halo, the commercial variant of a jointly-developed dual-use platform built to serve both defense and commercial applications. Anduril unveiled Thunder, the defense variant of the platform, on Monday at the Farnborough International Airshow. The two variants share the same airframe, hybrid powertrain and core systems, with configurable payload depending on mission requirements. Archer Technology Stack This new d...
-
SS&C GlobeOp Forward Redemption Indicator
WINDSOR, Conn.--(BUSINESS WIRE)--SS&C GlobeOp Forward Redemption Indicator: July notifications 1.35%...
-
Agi to Announce Second Quarter 2026 Financial Results on August 5, 2026
SÃO PAULO--(BUSINESS WIRE)--Agi Inc (NYSE: AGBK) (“Agi”), a bank that operates a hybrid platform combining the efficiency and scalability of digital with the proximity and service of a physical presence, today announced that it will release its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market closes. The Company will also host a conference call to discuss its results on the same day at 5:00pm ET (6:00pm BRT). The conference call can be accessed live over the...
-
CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its AirSeal® Robotic Solution is now indicated for use with Intuitive’s 8 mm hex cannulas used as part of the Intuitive da Vinci 5 platform (“dV5”). Alongside its existing indication for Intuitive 8 mm round cannulas, the AirSeal Robotic Solution now has an expanded indication for use across Intuitive’s portfolio of da Vinci X, da Vinci Xi, and da Vinci 5 robotic systems. Building on the existing indication for I...
-
First BanCorp. Announces Earnings for the Quarter Ended June 30, 2026
SAN JUAN, Puerto Rico--(BUSINESS WIRE)--First BanCorp. (the “Corporation” or “First BanCorp.”) (NYSE: FBP), the bank holding company for FirstBank Puerto Rico (“FirstBank” or “the Bank”), today reported a net income of $96.1 million, or $0.62 per diluted share, for the second quarter of 2026, compared to $88.8 million, or $0.57 per diluted share, for the first quarter of 2026, and $80.2 million, or $0.50 per diluted share, for the second quarter of 2025. Aurelio Alemán, President and Chief Ex...
-
CDW to Announce Second Quarter 2026 Results on August 5
VERNON HILLS, Ill.--(BUSINESS WIRE)--CDW Corporation (Nasdaq: CDW) announced today that it will host a webcast conference call to discuss its second quarter 2026 results on Wednesday, August 5, 2026, at 7:30 a.m. CT/8:30 a.m. ET. A live webcast (audio with slides) of the conference call will be accessible at investor.CDW.com. The press release and presentation slides will be posted on this website prior to the call. Please visit the website at least fifteen minutes prior to the call to register...